Literature DB >> 23982752

Reactivation of Х chromosome upon reprogramming leads to changes in the replication pattern and 5hmC accumulation.

Alexandra N Bogomazova1, Maria A Lagarkova, Alexandra V Panova, Evgueny D Nekrasov, Sergey L Kiselev.   

Abstract

Once set, the inactive status of the X chromosome in female somatic cells is preserved throughout subsequent cell divisions. The inactive status of the X chromosome is characterized by many features, including late replication. In contrast to induced pluripotent stem cells (iPSCs) in mice, the X chromosome in human female iPSCs usually remains inactive after reprogramming of somatic cells to the pluripotent state, although recent studies point to the possibility of reactivation of the X chromosome. Here, we demonstrated that, during reprogramming, the inactive X chromosome switches from late to synchronous replication, with restoration of the transcription of previously silenced genes. This process is accompanied by accumulation of a new epigenetic mark or intermediate of the DNA demethylation pathway, 5-hydroxymethylcytosine (5hmC), on the activated X chromosome. Our results indicate that the active status of the X chromosome is better confirmed by early replication and the reappearance of 5hmC, rather than by appearance of histone marks of active chromatin, removal of histone marks of inactive chromatin, or an absence of XIST coating.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982752     DOI: 10.1007/s00412-013-0433-x

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  39 in total

Review 1.  Mechanisms and consequences of widespread random monoallelic expression.

Authors:  Andrew Chess
Journal:  Nat Rev Genet       Date:  2012-05-15       Impact factor: 53.242

2.  X-Inactivation and histone H4 acetylation in embryonic stem cells.

Authors:  A M Keohane; L P O'neill; N D Belyaev; J S Lavender; B M Turner
Journal:  Dev Biol       Date:  1996-12-15       Impact factor: 3.582

3.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

Review 4.  Genetic and epigenetic stability of human pluripotent stem cells.

Authors:  Riikka J Lund; Elisa Närvä; Riitta Lahesmaa
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

5.  Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale.

Authors:  Maria A Lagarkova; Maria V Shutova; Alexandra N Bogomazova; Ekaterina M Vassina; Evgeny A Glazov; Ping Zhang; Albert A Rizvanov; Ilya V Chestkov; Sergey L Kiselev
Journal:  Cell Cycle       Date:  2010-03-06       Impact factor: 4.534

6.  Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.

Authors:  Claudia A Doege; Keiichi Inoue; Toru Yamashita; David B Rhee; Skylar Travis; Ryousuke Fujita; Paolo Guarnieri; Govind Bhagat; William B Vanti; Alan Shih; Ross L Levine; Sara Nik; Emily I Chen; Asa Abeliovich
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

7.  Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development.

Authors:  Meelad M Dawlaty; Achim Breiling; Thuc Le; Günter Raddatz; M Inmaculada Barrasa; Albert W Cheng; Qing Gao; Benjamin E Powell; Zhe Li; Mingjiang Xu; Kym F Faull; Frank Lyko; Rudolf Jaenisch
Journal:  Dev Cell       Date:  2013-01-24       Impact factor: 12.270

8.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

9.  Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells.

Authors:  Jonathan H Teichroeb; Dean H Betts; Homayoun Vaziri
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

10.  Nanog is the gateway to the pluripotent ground state.

Authors:  Jose Silva; Jennifer Nichols; Thorold W Theunissen; Ge Guo; Anouk L van Oosten; Ornella Barrandon; Jason Wray; Shinya Yamanaka; Ian Chambers; Austin Smith
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

View more
  5 in total

Review 1.  X chromosome inactivation: recent advances and a look forward.

Authors:  Sharon F Briggs; Renee A Reijo Pera
Journal:  Curr Opin Genet Dev       Date:  2014-10-27       Impact factor: 5.578

2.  Incorporation of 5-ethynyl-2'-deoxyuridine (EdU) as a novel strategy for identification of the skewed X inactivation pattern in balanced and unbalanced X-rearrangements.

Authors:  Luiza Sisdelli; Angela Cristina Vidi; Mariana Moysés-Oliveira; Adriana Di Battista; Adriana Bortolai; Danilo Moretti-Ferreira; Magnus R Dias da Silva; Maria Isabel Melaragno; Gianna Carvalheira
Journal:  Hum Genet       Date:  2015-12-15       Impact factor: 4.132

3.  Single-Cell XIST Expression in Human Preimplantation Embryos and Newly Reprogrammed Female Induced Pluripotent Stem Cells.

Authors:  Sharon F Briggs; Antonia A Dominguez; Shawn L Chavez; Renee A Reijo Pera
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

4.  Genome-wide 5-hydroxymethylcytosine patterns in human spermatogenesis are associated with semen quality.

Authors:  Olga A Efimova; Anna A Pendina; Andrei V Tikhonov; Sergey E Parfenyev; Irina D Mekina; Evgeniia M Komarova; Mariia A Mazilina; Eugene V Daev; Olga G Chiryaeva; Ilona A Galembo; Mikhail I Krapivin; Oleg S Glotov; Irina S Stepanova; Svetlana A Shlykova; Igor Yu Kogan; Alexander M Gzgzyan; Tatyana V Kuznetzova; Vladislav S Baranov
Journal:  Oncotarget       Date:  2017-06-01

5.  Epigenetic reprogramming by naïve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells.

Authors:  Alexandra V Panova; Alexandra N Bogomazova; Maria A Lagarkova; Sergey L Kiselev
Journal:  Oncotarget       Date:  2018-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.